Search results for the GEO ID: GSE22152
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM550942
GPL570
GC resistant clone C7H2-R10E7 treated for 6 hours with EtOH GC resistant clone C7H2-R10E7 treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: TRUE treatment: EtOH GC resistant clone C7H2-R10E7 treated for 6 hours with 0.1% ethanol (carrier control).
GSM550943
GPL570
GC resistant clone C7H2-R19E5 treated for 6 hours with EtOH GC resistant clone C7H2-R19E5 treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: TRUE treatment: EtOH GC resistant clone C7H2-R19E5 treated for 6 hours with 0.1% ethanol (carrier control).
GSM550944
GPL570
GC resistant clone C7H2-R9C10 treated for 6 hours with EtOH GC resistant clone C7H2-R9C10 treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: TRUE treatment: EtOH GC resistant clone C7H2-R9C10 treated for 6 hours with 0.1% ethanol (carrier control).
GSM550945
GPL570
GC resistant clone C7H2-R3B5 treated for 6 hours with EtOH GC resistant clone C7H2-R3B5 treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: TRUE treatment: EtOH GC resistant clone C7H2-R3B5 treated for 6 hours with 0.1% ethanol (carrier control).
GSM550946
GPL570
GC resistant clone C7H2-R19F2 treated for 6 hours with EtOH GC resistant clone C7H2-R19F2 treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: TRUE treatment: EtOH GC resistant clone C7H2-R19F2 treated for 6 hours with 0.1% ethanol (carrier control).
GSM550947
GPL570
GC resistant clone C7H2-R19E7 treated for 6 hours with EtOH GC resistant clone C7H2-R19E7 treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: TRUE treatment: EtOH GC resistant clone C7H2-R19E7 treated for 6 hours with 0.1% ethanol (carrier control).
GSM550948
GPL570
GC sensitive clone C7H2-S11 treated for 6 hours with EtOH GC sensitive clone C7H2-S11 treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: FALSE treatment: EtOH GC sensitive clone C7H2-S11 treated for 6 hours with 0.1% ethanol (carrier control).
GSM550949
GPL570
GC sensitive clone C7H2-S12 treated for 6 hours with EtOH GC sensitive clone C7H2-S12 treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: FALSE treatment: EtOH GC sensitive clone C7H2-S12 treated for 6 hours with 0.1% ethanol (carrier control).
GSM550950
GPL570
GC sensitive clone C7H2-S27(ZR) treated for 6 hours with EtOH GC sensitive clone C7H2-S27(ZR) treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: FALSE treatment: EtOH GC sensitive clone C7H2-S27(ZR) treated for 6 hours with 0.1% ethanol (carrier control).
GSM550951
GPL570
GC sensitive clone C7H2-S10 treated for 6 hours with EtOH GC sensitive clone C7H2-S10 treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: FALSE treatment: EtOH GC sensitive clone C7H2-S10 treated for 6 hours with 0.1% ethanol (carrier control).
GSM550952
GPL570
GC sensitive clone C7H2-S2 treated for 6 hours with EtOH GC sensitive clone C7H2-S2 treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: FALSE treatment: EtOH GC sensitive clone C7H2-S2 treated for 6 hours with 0.1% ethanol (carrier control).
GSM550953
GPL570
GC sensitive clone C7H2-S15 treated for 6 hours with EtOH GC sensitive clone C7H2-S15 treated for 6 hours with EtOH cell type: lymphoblastic leukemia gc resistant: FALSE treatment: EtOH GC sensitive clone C7H2-S15 treated for 6 hours with 0.1% ethanol (carrier control).
GSM550954
GPL570
GC resistant clone C7H2-R10E7 treated for 6 hours with GC GC resistant clone C7H2-R10E7 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: TRUE treatment: GC GC resistant clone C7H2-R10E7 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
GSM550955
GPL570
GC resistant clone C7H2-R19E5 treated for 6 hours with GC GC resistant clone C7H2-R19E5 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: TRUE treatment: GC GC resistant clone C7H2-R19E5 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
GSM550956
GPL570
GC resistant clone C7H2-R9C10 treated for 6 hours with GC GC resistant clone C7H2-R9C10 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: TRUE treatment: GC GC resistant clone C7H2-R9C10 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
GSM550957
GPL570
GC resistant clone C7H2-R3B5 treated for 6 hours with GC GC resistant clone C7H2-R3B5 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: TRUE treatment: GC GC resistant clone C7H2-R3B5 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
GSM550958
GPL570
GC resistant clone C7H2-R19F2 treated for 6 hours with GC GC resistant clone C7H2-R19F2 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: TRUE treatment: GC GC resistant clone C7H2-R19F2 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
GSM550959
GPL570
GC resistant clone C7H2-R19E7 treated for 6 hours with GC GC resistant clone C7H2-R19E7 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: TRUE treatment: GC GC resistant clone C7H2-R19E7 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
GSM550960
GPL570
GC sensitive clone C7H2-S11 treated for 6 hours with GC GC sensitive clone C7H2-S11 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: FALSE treatment: GC GC sensitive clone C7H2-S11 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
GSM550961
GPL570
GC sensitive clone C7H2-S12 treated for 6 hours with GC GC sensitive clone C7H2-S12 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: FALSE treatment: GC GC sensitive clone C7H2-S12 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
GSM550962
GPL570
GC sensitive clone C7H2-S27 treated for 6 hours with GC GC sensitive clone C7H2-S27 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: FALSE treatment: GC GC sensitive clone C7H2-S27 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
GSM550963
GPL570
GC sensitive clone C7H2-S10 treated for 6 hours with GC GC sensitive clone C7H2-S10 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: FALSE treatment: GC GC sensitive clone C7H2-S10 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
GSM550964
GPL570
GC sensitive clone C7H2-S2 treated for 6 hours with GC GC sensitive clone C7H2-S2 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: FALSE treatment: GC GC sensitive clone C7H2-S2 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
GSM550965
GPL570
GC sensitive clone C7H2-S15 treated for 6 hours with GC GC sensitive clone C7H2-S15 treated for 6 hours with GC cell type: lymphoblastic leukemia gc resistant: FALSE treatment: GC GC sensitive clone C7H2-S15 treated for 6 hours with 100nM dexamethasone (a glucocorticoid).
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes